Armstrong Advisory Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$163K Sell
1,571
-600
-28% -$53.6K 0.01% 280
2026
Q1
$156K Hold
2,171
0.01% 263
2025
Q4
$172K Buy
2,171
+160
+8% +$12.6K 0.01% 244
2025
Q3
$152K Sell
2,011
-185
-8% -$12.7K 0.01% 249
2025
Q2
$151K Buy
2,196
+1,000
+84% +$65.6K 0.01% 234
2025
Q1
$53.7K Hold
1,196
﹤0.01% 367
2024
Q4
$53.7K Hold
1,196
﹤0.01% 367
2024
Q3
$75.2K Sell
1,196
-343
-22% -$20K 0.01% 310
2024
Q2
$90.9K Sell
1,539
-266
-15% -$16.6K 0.01% 274
2024
Q1
$143K Hold
1,805
0.01% 210
2023
Q4
$143K Buy
1,805
+58
+3% +$4.13K 0.01% 210
2023
Q3
$122K Sell
1,747
-607
-26% -$43K 0.01% 210
2023
Q2
$163K Sell
2,354
-389
-14% -$27.7K 0.02% 194
2023
Q1
$204K Sell
2,743
-212
-7% -$17.8K 0.02% 158
2022
Q4
$275K Buy
+2,955
New +$285K 0.04% 135

Other funds holding CVS

Armstrong Advisory Group's CVS Position: Q2 2026 in Review

Armstrong Advisory Group reduced its CVS Health (CVS) stake by 28% in Q2 2026, selling an estimated $53.6K and leaving 1,571 shares worth $163K. The position accounts for 0.01% of the portfolio, ranked #280.

Armstrong Advisory Group first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $275K in Q4 2022. 446 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Armstrong Advisory Group held 1,571 shares of CVS Health worth $163K as of Q2 2026.
  • Armstrong Advisory Group sold 600 CVS Health shares in Q2 2026, an estimated $53.6K.
  • CVS Health made up 0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #280 holding.
  • Armstrong Advisory Group first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's CVS Health position peaked at $275K in Q4 2022.
  • 446 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.